InvestorsHub Logo
Followers 126
Posts 5413
Boards Moderated 0
Alias Born 06/09/2020

Re: learningcurve2020 post# 490175

Sunday, 06/26/2022 11:37:54 AM

Sunday, June 26, 2022 11:37:54 AM

Post# of 700141
Love it LC.

Especially since Merck went out of their way to make UCLA "change partner" in 2019 and derailed Opdivo as the PD-1 inhibitor in the prestigious SPORE 1 project, the combo trial with Keytruda and DCVax-L.

One might be inclined to wonder a bit about your take regarding DCVax-L's potential and outlook, when the big boys league gather round DCVax-L.

Guess they never came about your take. What a pity.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News